India outlines 14 "essential elements" of informed consent for drug trials
This article was originally published in Scrip
Executive Summary
Companies that are sponsors of clinical trials undertaken in India will have to abide be new requirements for informed consent documents. India's Central Drugs Standard Control Organization has laid out 14 "essential elements" that must be included in such documents used to enrol subjects in a drug trial.